252 results
424B5
LCTX
Lineage Cell Therapeutics Inc
14 May 24
Prospectus supplement for primary offering
4:36pm
average exercise price of $1.53 per share awarded under our 2021 Equity Incentive Plan, as amended (our “2021 Equity Incentive Plan”), our 2012 Equity … Incentive Plan, as amended (together with our 2021 Equity Incentive Plan, our “equity incentive plans”), or outside of our equity incentive plans
424B5
LCTX
Lineage Cell Therapeutics Inc
22 Mar 24
Prospectus supplement for primary offering
4:32pm
exercise price of $1.62 per share awarded under our 2021 Equity Incentive Plan, as amended (our “2021 Equity Incentive Plan”), our 2012 Equity Incentive … Plan, as amended (together with our 2021 Equity Incentive Plan, our “equity incentive plans”), or outside of our equity incentive plans pursuant
424B5
1zv8w80d
6 Feb 24
Prospectus supplement for primary offering
9:25am
8-K
EX-10.1
r8180
6 Feb 24
Lineage Cell Therapeutics Announces $14.0 Million Registered Direct Offering
9:20am
S-8
EX-5.1
u0befbabp7higr ntxs
13 Nov 23
Registration of securities for employees
4:19pm
S-8
nb5jplc
13 Nov 23
Registration of securities for employees
4:19pm
S-8
ck7pvgbz87ro70gj2ff
13 Nov 23
Registration of securities for employees
4:19pm
8-K
22pwhliue48
7 Sep 23
Departure of Directors or Certain Officers
5:01pm